Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of Care

    Details
    Basic Details
    Date
    Friday, August 9, 2019
    Entity
    BBCIC
    Type
    Publication
    Description

    As clinical trials test efficacy rather than effectiveness of medications, real-world effectiveness data often vary from clinical trial data. Given the recent market entry of multiple biologics and biosimilars, a dedicated assessment of these diverse agents is needed to build the evidence base regarding efficacy and safety of innovator biologics and biosimilars. The Academy of Managed Care Pharmacy’s Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) was convened to address the lack of real-world, postmarket outcome evidence generation for innovator biologics and corresponding biosimilars.

    Contributors
    Author(s)

    Cheryl N. McMahill-Walraven, Daniel J. Kent, Catherine A. Panozzo, Pamala A. Pawloski, Kevin Haynes, James Marshall, Jeffrey Brown, Bernadette Eichelberger, Catherine M. Lockhart